Lansoprazole (Prevacid Fastab, Prevacid) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Sep 4, 2026
Some Lansoprazole products are in shortage in Canada (7 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 9, 2027.
A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.
Products affected
7 / 22
In shortage since
Sep 3, 2024
Est. full return
Mar 9, 2027
Reports on file
125
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-LANSOPRAZOLE
30MG · CAPSULE (DELAYED-RELEASE) · APOTEX INC
DIN 02293838 · since Sep 1, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-LANSOPRAZOLE
30MG · CAPSULE (DELAYED-RELEASE) · APOTEX INC
DIN 02293838 · since Sep 1, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
DIN 02385651 · ended Feb 16, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Lansoprazole is currently affected by 7 active shortage reports filed with Health Canada by APOTEX INC, MYLAN PHARMACEUTICALS ULC, MANTRA PHARMA INC, LABORATOIRE RIVA INC..
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lansoprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).
Recent changes
Sep 4, 2026
New report filed
Sep 4, 2026
New report filed
Sep 3, 2026
Estimated end date pushed back : Dec 29, 2026 → Mar 9, 2027
Sep 3, 2026
Estimated end date pushed back : Dec 29, 2026 → Mar 9, 2027
Common questions
What is Lansoprazole used for?
A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.
When will Lansoprazole be back in stock in Canada?
The latest manufacturer estimate is Mar 9, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lansoprazole in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.